You are here

Qulipta

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment

BioSpace

Mon, 04/15/24 - 11:06 am

clinical trials

AAN 2023: AbbVie highlights Qulipta’s edge over oral migraine prophylaxis

Clinical Trials Arena

Wed, 04/26/23 - 10:05 am

chronic migraine

FDA expands Qulipta indication to include chronic migraine prevention

Healio

Tue, 04/18/23 - 10:13 pm

AbbVie files Qulipta for chronic migraine prevention

Pharmaforum

Wed, 06/22/22 - 10:21 am

AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up

Fierce Pharma

Thu, 03/10/22 - 10:22 pm

AbbVie runs first Qulipta TV ad spots as it focuses on what you ‘can control inside’

Fierce Pharma

Fri, 02/11/22 - 11:46 am

pharma marketing

AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec

Fierce Pharma

Thu, 02/10/22 - 08:02 pm

AbbVie’s Qulipta Set to Become Blockbuster in the Migraine Market

Clinical Trials Arena

Sun, 10/3/21 - 08:11 pm

AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug

Endpoints

Wed, 09/29/21 - 11:04 am